Carprodyl Quadri

20 x 6 pc
Chewable tablet
PA
PO

Active substance

  • Carprofen : 120 mg
  • Species

    Dogs.

    Indications

    In the dog:

    Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease.

    As a follow-up to parenteral analgesia in the management of post-operative pain.

    Dose to be administered and administration route

    For oral administration.

    4 mg carprofen per kg bodyweight per day.

    An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours.

    The daily dose may be reduced, subject to clinical response.

    Duration of treatment will be dependent upon the response seen. Long term treatment should be under regular veterinary supervision.

    To extend analgesic and anti-inflammatory cover post-operatively parenteral preoperative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days. Do not exceed the stated dose.

    Tablets can be broken as follows: Put the tablet on a flat surface, with its scored side facing the surface (convex face up).

    With the tip of forefinger, exert a slight vertical pressure on the middle of the tablet to break it into halves. In order to obtain quarters, then exert a slight pressure on the middle of one half with forefinger.

    Each chewable tablet can be quartered for accurate dosing according to the individual body weight of the animal.

    Number of tablets per day

     

    Dog weight (kg)

    ¼

    ≥ 7.5

    < 14.4

    ½

    ≥ 14.5 

    < 20.9

    ¾

    ≥ 21

    < 29.9

    1

    ≥ 30

    < 37.4

    1 ¼

    ≥ 37.5

    < 44.9

    1 ½

    ≥ 45

    < 52.4

    1 ¾

    ≥ 52.5

    < 59.9

    2

    ≥ 60

    < 70

    The chewable tablets are flavoured and are accepted by dogs. The chewable tablets can be administered with or without food.

    Adverse reactions

    Typical undesirable effects associated with NSAID, such as vomiting, soft faeces/diarrhea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions generally occur within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

    If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.

    As with other NSAID there is a risk of rare renal or idiosyncratic hepatic adverse events.

    Dispensing

    POM-V

    References

    Leaflet is unavailable
    Dog
    PRICE Only for registered vets. Create a free profile to access all features.. Login
    Art. Nr. 15052/5059
    EAN 3411112264469
    PACKAGES
    Carprodyl Quadri
    Ceva Animal Health
    20 x 6 pc
    15052/5059
    VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
    VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.